e7777
Showing 1 - 4 of 4
Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)
Not yet recruiting
- Epithelial Ovarian Cancer
- Pembrolizumab
- E7777
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 4, 2022
DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)
Recruiting
- DLBCL
- +3 more
- E7777
-
Minneapolis, MinnesotaUniversity of Minnesota, Masonic Cancer Center
Jul 1, 2022
Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Japan (E7777)
Completed
- Peripheral T-cell Lymphoma
- Cutaneous T-cell Lymphoma
- E7777
-
Nagoya, Aichi, Japan
- +19 more
Jun 24, 2021
Peripheral T-Cell Lymphoma Trial in Skokie, Morristown (E7777)
Withdrawn
- Peripheral T-Cell Lymphoma
- E7777
-
Skokie, Illinois
- +1 more
Nov 14, 2013